NCT06062966View on ClinicalTrials.gov

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Heart Failure

Interventions

DRUG

Anakinra

Anakinra 100 mg SC daily will be administered to sujects on chronic inotrope treatment who are not candidates for transplantation or left ventricular assist device (LVAD).

Trial Locations (1)

23284

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors

lead

Virginia Commonwealth University

OTHER